TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 22 filers reported holding TRANSPHORM INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $385,000 | – | 54,397 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 609,170 | $4,307,000 | 1.99% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 374,226 | $2,646,000 | 1.61% |
| Kohlberg Kravis Roberts & Co. L.P. | 22,175,980 | $156,784,000 | 1.42% |
| Foundation Capital, LLC | 136,004 | $962,000 | 0.62% |
| Soros Fund Management | 673,991 | $4,765,000 | 0.07% |
| Polar Asset Management Partners Inc. | 867,500 | $6,133,000 | 0.07% |
| ExodusPoint Capital Management, LP | 89,499 | $633,000 | 0.01% |
| AMERIPRISE FINANCIAL INC | 3,602,481 | $25,470,000 | 0.01% |
| Weiss Asset Management LP | 43,600 | $308,000 | 0.01% |
| Ergoteles LLC | 18,900 | $134,000 | 0.01% |